Lloyd Price

NOVEMBER 21, 2023

By implementing these strategies, Palantir can effectively address public concerns, build trust, and gain acceptance for its role in delivering the NHS Federated Data Platform, ultimately contributing to improved patient care and healthcare outcomes in England. Palantir's products are used by a variety of industries, including healthcare.

Drug Development 70

Drug Development Health science healthcare technology Leadership 70

Lloyd Price

MAY 2, 2024

Exec Summary: Nvidia's strategy for healthcare revolves around leveraging their expertise in high-performance computing and AI to revolutionise various aspects of the healthcare industry. HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis.

healthcare technology 73

healthcare technology Drug Development Leadership Digital Health 73

Lloyd Price

MAY 6, 2024

Exec Summary: AI has revolutionised the weather industry by providing faster, more accurate, and personalised weather predictions. This has significant benefits for public safety, disaster preparedness, and various industries that rely on weather information. Visit www.nelsonadvisors.co.uk Subscribe Today! Subscribe Today!

healthcare technology 70

healthcare technology Leadership Drug Development Digital Health 70

Lloyd Price

FEBRUARY 18, 2024

Mergers and acquisitions: The promising future of GLP-1s led to several mergers and acquisitions within the healthtech industry. These deals aimed to consolidate market share, expand research capabilities, and accelerate product development, further stimulating investor interest. Subscribe Today!

Pharmaceuticals 60

Pharmaceuticals healthcare technology Leadership Drug Development 60

Lloyd Price

FEBRUARY 2, 2024

Benefits for healthcare stakeholders: Streamlined patient onboarding: Verifiable credentials from SSI wallets can expedite patient registration and verification, reducing administrative burdens and improving wait times. Regulatory frameworks and industry-wide collaboration are key drivers. Subscribe Today! Subscribe Today!

Health Data 64

Health Data Interoperability healthcare technology Leadership 64

Healthcare IT Today

NOVEMBER 14, 2022

Brad Whitmore is a successful investor who has targeted a broad range of investments across various industries with an emphasis on businesses with long-term, sustainable competitive advantages and unique offerings relative to competitors. Within Life Sciences, the firm focuses on MedTech, Diagnostics, and Opportunistic Drug Development.

Life Science 95

Life Science HIPAA Drug Development healthcare technology 95

Healthcare IT Today

MAY 5, 2023

Whereas a traditional visit to the doctor can analyze one’s physical health in a fixed time, technology can gather data throughout a patient’s lived experiences, helping healthcare professionals understand patient backgrounds, experiences, and personal preferences on a deeper level.

Drug Development 87

Drug Development Primary Care Remote care Patient Experience 87